--- title: "AIRO Reports Q1 2026: Revenue $8.9M, Net Loss $15.5M, Adjusted EBITDA $(12.8) M" type: "News" locale: "en" url: "https://longbridge.com/en/news/286402532.md" description: "AIRO reported Q1 2026 results with revenue of $8.9 million and a net loss of $15.5 million. The gross profit was $2.4 million, with a gross margin of 26.6%. Adjusted EBITDA was $(12.8) million. The company reiterated its full-year revenue growth guidance of 15%-25% and introduced Adjusted EBITDA guidance in the negative mid- to high-teens million dollar range. AIRO launched an AI-enabled RQ-35 variant and expanded its drone portfolio, maintaining a backlog exceeding $150 million as of April 30, 2026." datetime: "2026-05-14T10:53:00.000Z" locales: - [zh-CN](https://longbridge.com/zh-CN/news/286402532.md) - [en](https://longbridge.com/en/news/286402532.md) - [zh-HK](https://longbridge.com/zh-HK/news/286402532.md) --- # AIRO Reports Q1 2026: Revenue $8.9M, Net Loss $15.5M, Adjusted EBITDA $(12.8) M AIRO reported first-quarter 2026 results with revenue of $8.9 million and a net loss of $15.5 million for the period ended March 31, 2026. The company recorded gross profit of $2.4 million (26.6% gross margin) and reported Adjusted EBITDA of $(12.8) million. AIRO reiterated full-year 2026 revenue growth guidance of 15%–25% and introduced full-year Adjusted EBITDA guidance in the negative mid- to high-teens million dollar range. **Financial Highlights** - Revenue: $8.9 million for Q1 2026, compared with $11.8 million in Q1 2025. - Gross profit: $2.4 million; gross margin 26.6% (versus $6.9 million and 58.8% in Q1 2025). - Operating loss: $(17.2) million for Q1 2026 (compared with $(3.1) million in Q1 2025). - Net loss: $(15.5) million for Q1 2026 (compared with $(2.0) million in Q1 2025); net loss per share — basic and diluted: $(0.49). - Adjusted EBITDA: $(12.8) million for Q1 2026 (compared with $0.1 million in Q1 2025). **Business Highlights** - Launched an AI-enabled full-stack RQ-35 variant to improve performance in GPS-denied environments and advance ISR capabilities. - Refocused product strategy toward cargo and ISR markets, expanding the medium-lift drone portfolio with the JX250 and JC250 designs targeting ~1,000 miles range and up to 16 hours endurance in ISR configurations; first flight targeted in 2026 with commercialization expected in 2027. - Scaled manufacturing capacity at the Støvring, Denmark facility, increasing production capacity by approximately 30% above current backlog levels to support future demand. - Evaluating strategic alternatives for the Training segment to sharpen focus on drone markets while assessing capital allocation and long-term fit. - Maintained drone backlog in excess of $150 million as of April 30, 2026, with management expecting the majority to convert to revenue over the next 12 months. Original SEC Filing: AIRO Group Holdings, Inc. \[ AIRO \] - 8-K - May. 14, 2026 **Disclaimer** This is an AI-powered summary. It may contain inaccuracies. Consider verifying important information with the source. Please note this summary is solely based on documents filed with the SEC. ### Related Stocks - [AIRO.US](https://longbridge.com/en/quote/AIRO.US.md) - [PPA.US](https://longbridge.com/en/quote/PPA.US.md) - [XAR.US](https://longbridge.com/en/quote/XAR.US.md) - [ITA.US](https://longbridge.com/en/quote/ITA.US.md) ## Related News & Research - [AIRO Group Q1 revenue falls more than expected, hurt by shipment timing](https://longbridge.com/en/news/286400238.md) - [Draganfly (CNSX:DPRO) Deepens U.S. Ties and Japan Alliance Is Its Drone Platform Strategy Converging?](https://longbridge.com/en/news/285980042.md) - [Local authorities report that Russia’s Nizhny Novgorod region has come under drone attack.](https://longbridge.com/en/news/287007886.md) - [NATO Chief Rutte: NATO has made a calm, decisive, and proportionate response to recent drone incursions.](https://longbridge.com/en/news/287042178.md) - [ONWARD Medical to Announce First Quarter 2026 Results on May 26, 2026 | ONWRY Stock News](https://longbridge.com/en/news/286858298.md)